The strength of Manta® lies in its ability to rapidly and accurately analyze complex biomedical data
from a patient, enabling rapid and accurate diagnosis, a crucial aspect in the fight against serious
disease.
This capability enables rapid, reliable and tangible diagnosis: a vital element in the fight
against serious diseases.
Thanks to this technology, every patient benefits from precision care, tailored to his or her
pathophysiological condition and stage of disease.
Finally, Manta® promises to offer remote areas and developing countries the same access to care as
large medical centers.
For healthcare professionals, insurance companies or employers concerned about the health of their
employees, Manta® is a powerful decision-making companion that simplifies and rationalizes access to
patient care.
It transforms the analysis of complex patient biological data into relevant, intelligible
information, helping doctors to establish optimal treatment plans quickly and confidently.
This efficiency contributes to improved patient outcomes and a significant reduction in the length
and cost of care, reducing the need for prolonged or ill-adapted treatments.
Harnessing language processing and deep learning models for accurate medical insights.
Unique digital twins mimic patient conditions, offering personalized treatment paths.
Combines imaging, medical reports, and biological analyses for a comprehensive health overview.
Acting as a an entry point to collect data coming from
multiple
biomedical sensors and technical platforms, Manta®'s digital DataLife
Insight tool plays a
critical role by analyzing a patient's Data.It accomodates a wide range of
data such as
integration of analysis of biological fluids (blood, plasma, urine),
analyses from
biomedical platform (genomics, transcriptome, proteome, metabolome,
phenotype), or even
semantical data as communications between clinicians.
This module matches the unique data of the patient with a specific disease
from our vast
library of numerical models of pathologies.
The chosen disease model is then enriched with the
patient's real,
up-to-date health information.
This integration step creates a "digital twin," aka a virtual version of the
patient that
mirrors their real condition. This provides the medical team with a detailed
and dynamic
overview of the patient's health status. While this would take several
weeks, here on
digital twins, analyses and tests can be performed in only few minutes,
without any risk to
the patient.
BioClarity enhances this analysis by exploring
causality, hierarchy,
and sequences of events within at all physiological scales, from
intracellular to
inter-organ levels.
Its deep understanding of the
mechanisms of action allows BioClarity to precisely evaluate the
disease's progression stage, incorporating actual medical data from
the patient.
Finally, the MoleculeAI Insight module steps in to
recommend the
most promising medication for treatment.
It reviews current
treatment options, including potential therapeutic repositioning,
and assesses the efficacy of new molecules.
This analysis is
grounded in a comprehensive review of global biomedical research,
enabling MoleculAI Insight to provide a precise therapeutic plan
supported by scientific literature evidence, ensuring that each
therapeutic proposition is based on the most current and relevant
data.
Your Health Data secured on our servers, we do not share data with anybody
Also... You wonder about data security and device frugality? Well: here we need no cloud infrastructure, no data sharing. Manta® works autonomously on both smart phone or personnal computer, Manta® facilitate diagnostics and therapeutics decisions, even in remote environments, from medical desert as mining and off shore platforms, to deep space exploration.
Manta® reduces overall healthcare expenditures by minimizing misdiagnoses and ineffective treatments.
Quick and precise diagnostic capabilities lead to timely and effective treatment plans.
Manta®'s digital reach ensures quality healthcare access, even in medically underserved regions.
"Strong prospective insight from identification of mechanism of action in Breast cancer progression"
E. B.
Research Director CNRS, France"Fresher and more powerfull than a chatGPT for health, far more advanced than the regular offer"
Undisclosed
Stakeholder, Mayo Clinic, USA"You are one of the very few that are working on something is of outmost importance: causality"
E.G.
Senior director, Artificial Intelligence Institute, France"Really cool work"
L.LD.
Senior Business Developper and serial entrepreneur, Serie B and IPO companies, USA"Really interesting approaches, totally in phase"
M.C.
MD, Professor and Director of Hospital and associate partner, International Clinical cluster"Happy to have found you"
B. B.
Pharm.D., Professor, France"Answering totally to an unmet need in medicine"
F.B.
MD, Professor, University Hospital, France"Super interesting and exciting"
MB. M.
MD, Professor, University Hospital, France"Intersting insights from complex experimental data"
J.P.
MD and CSO, Serie B Biotech company, Belgium"Exactly what we need"
A.BT.
CEO, Medtech company, France"We have to work together"
T.S.
CEO, Medtech company, France"Really powerfull for clinical trials and pivots"
D.P.
Business developper, Roche Diagnostics, France"Very interesting value proposition and offer, you should definitely push it forward"
Undisclosed
Stakeholder, European Space Agency"Very happy to work together"
P.K.
Professor, MIT fellow and Partner in Medtech multinational Serie B company"Very deep and exhaustive research information for our consortium"
O.S.
Senior Partner, PWC, Switzerland"Thank you a lot for your help, you saved us so much time!"
I.H.
Partner, PWC, SwirtzerlandTimely access to specialized diagnosis is crucial as delays can lead to
worsening health conditions, especially in complex cases with comorbidities.
Manta® addresses this gap by providing rapid, accurate diagnostic insights,
reducing wait times and improving patient outcomes, particularly in regions
with limited access to specialist care.
Clinicians often face the overwhelming task of analyzing vast amounts of
medical data.
Manta® simplifies this by integrating and interpreting diverse
data sources, such as imaging, medical reports, and biological analyses, using
advanced AI algorithms.
This aids clinicians in making more informed and
efficient decisions.
Manta® democratizes access to advanced medical diagnostics, particularly
in medically underserved areas.
Its digital platform enables clinicians in remote
locations to provide high-quality care by offering quick and comprehensive
diagnostic insights, thus overcoming geographical and resource barriers.
Absolutely.
By providing accurate and timely diagnoses, Manta® helps to
reduce unnecessary procedures, medication errors, and hospital readmissions.
This not only improves patient outcomes but also significantly lowers
healthcare costs for both providers and patients.
Manta®'s AI algorithms are continually updated with the latest medical
research and data.
This ensures that its diagnostic and therapeutic
suggestions
are in line with current best practices, providing clinicians with up-to-date
information to make informed treatment decisions.
Yes, Manta®'s user-friendly and AI-driven platform enables non-medical
personnel in remote areas to obtain accurate medical diagnostics.
This is
especially valuable in environments where professional medical assistance is
not readily available, ensuring timely health interventions.